Jill Waibel, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Allergan
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Buasch
    Topic:
    Clinical Trial/Advisory Board
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Bellamia
    Topic:
    Scientific Advisory Board
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Clinical Trial
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Candela
    Topic:
    Scientific Advisory Borad
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Cytrellis Biosystems
    Topic:
    Scientific Advisory Board/ Clinical Trial
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Eli Lilly
    Topic:
    Clinical Trial, Speaker
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Estee Lauder
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Galderma
    Topic:
    Clinical Trial, Consultant
    Date added:
    07/27/2026
    Date updated:
    07/27/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Immunovant
    Topic:
    Clinical Trial
    Date added:
    07/27/2026
    Date updated:
    07/27/2026

Pages

Return to 2026 Science of Skin Summit